Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-1-18
pubmed:abstractText
This study reports the clinical and immunological state of patients 3 years after a 6-year period of Xolair treatment for severe allergic asthma.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1398-9995
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
56-60
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19796193-Adult, pubmed-meshheading:19796193-Aged, pubmed-meshheading:19796193-Allergens, pubmed-meshheading:19796193-Animals, pubmed-meshheading:19796193-Anti-Asthmatic Agents, pubmed-meshheading:19796193-Antibodies, Anti-Idiotypic, pubmed-meshheading:19796193-Antibodies, Monoclonal, pubmed-meshheading:19796193-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19796193-Asthma, pubmed-meshheading:19796193-Basophils, pubmed-meshheading:19796193-Cats, pubmed-meshheading:19796193-Clinical Trials as Topic, pubmed-meshheading:19796193-Follow-Up Studies, pubmed-meshheading:19796193-Forced Expiratory Volume, pubmed-meshheading:19796193-Humans, pubmed-meshheading:19796193-Hypersensitivity, pubmed-meshheading:19796193-Immunoglobulin E, pubmed-meshheading:19796193-Middle Aged, pubmed-meshheading:19796193-Questionnaires
pubmed:year
2010
pubmed:articleTitle
After 6 years with Xolair; a 3-year withdrawal follow-up.
pubmed:affiliation
Department of Medicine, Clinical Immunology and Allergy Unit, Karolinska Institute, Stockholm, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't